arrow
J

Jodie Palmer

olivia newton john cancer research institute
H指数:15
被引数:1,198

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Marked variation in eligibility criteria across registrational trials for relapsed diffuse large B-cell lymphoma limits applicability to clinical practice

复发弥漫性大B细胞淋巴瘤注册试验中纳入标准的显著差异限制了其在临床实践中的适用性

2026-05-150
OAAI
Checkpoint inhibitors, obinutuzumab plus PET-adapted ultra-low dose nodal radiotherapy yield high efficacy in treatment-naïve follicular lymphoma: Results from the phase II ‘FLUORO’ study

检查点抑制剂、奥比妥珠单抗联合PET适应性超低剂量结内放射治疗对初治滤泡性淋巴瘤具有高疗效:来自II期“FLUORO”研究的结果

2026-04-080
OAAI
A Bioimaging Study of 89Zr-Bintrafusp Alfa PET Scans in Patients with Advanced or Metastatic NSCLC Receiving Bintrafusp Alfa Alone or in Combination with Chemotherapy

89Zr-_bintrafusp alfa PET扫描的生物学成像研究:在单独接受bintrafusp alfa治疗或联合化疗的晚期或转移性非小细胞肺癌患者中的应用

2025-12-290
PRE
T-cell dysregulation informs radiotherapy-immunotherapy response in B-cell lymphoma: results from a phase 1 trial

T细胞失调与B细胞淋巴瘤的放疗-免疫疗法反应:一项1期试验的结果

2025-06-260
OAAI